Its not enough to entice Big Pharma to take on this drug in this indication. Progesterone had much better results in its TBI Phase 2 and it flunked its 3 year Phase 3 trial. Trials take too long for this indication.
This is the first flunk in ages for NEU so industry trends have caught up to it... but focus on the positives... its still got interesting pipeline....
Ann: Results of Phase 2 trial in moderate to severe TBI-NEU.AX, page-7
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.05 |
Change
-0.510(3.50%) |
Mkt cap ! $1.795B | |||
| Open | High | Low | Value | Volume |
| $14.38 | $14.42 | $13.94 | $6.419M | 454.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $13.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.07 | 6644 | 4 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |